The commercial law firm Gütt Olk Feldhaus (GOF) – with a team led by Dr Heiner Feldhaus (PICTURED LEFT) – has advised Maxburg Beteiligungen on the sale of GfS Gesellschaft für Sicherheitstechnik to ASSA ABLOY
Greenberg Traurig – with a team led by Dr. Kati Beckmann (PICTURED) and composed of Claudia Stremel, Peter Zingel, and Florian Deitel – advised FAP Group on the structuring and launch of a new real estate debt
A Noerr team led by Michael Brellochs, Florian Becker and Thomas Heitzer (ALL PICTURED, LEFT TO RIGHT) has advised the Generali Group as part of a consortium on the acquisition of the Viridium Group. Viridium
A CMS team led by partner Dr Malte Bruhns (PICTURED) played a leading role in providing legal and tax advice to the UX Group shareholders on the sale of the company to the Steliau Technology
Legal advisers from multi-billion-dollar companies have revealed how they expect law firms to evolve by the year 2035, in a new global survey published by international law firm Simmons & Simmons called “Law firm of the
DLA Piper has advised Keensight Capital on the acquisition of a majority stake in ACTICO Group. The management team of ACTICO Group and the existing shareholder Bregal Unternehmerkapital Funds (“BU Funds”), the largest mid-cap investor
Infrastructure investor Equitix has acquired a stake of approx. 15.2 per cent in the German offshore wind farm project Gode Wind 1 from The Renewables Infrastructure Group (TRIG). Ørsted, global leader in offshore wind and developer of
The International Bar Association (IBA) has unveiled the second phase of its comprehensive “50:50 by 2030” initiative, which aims to tackle persistent gender disparity in leadership positions throughout the legal sector. Working in partnership with LexisNexis‘ charitable
Funds managed by BU Bregal Unternehmerkapital – the largest and most active mid-cap investment company based in the DACH region – have signed an agreement with Keensight Capital – one of the leading private equity managers active in
A recent ruling by the Regional Court of Düsseldorf has determined that Pfizer and its German collaborator BioNTech must compensate Moderna, assisted by Freshfields, for utilizing its European Patent 949 (EP 949), marking a significant development
